Avacta granted EU approval for Covid-19 test
Listed biotechnology business Avacta Group has been granted approval to market its Covid-19 lateral flow test for professional use in the EU. The company has received notice of registration of its AffiDX SARS-CoV-2 antigen lateral flow test, enabling it to place the product on the market in all 27 countries of the EU for professional […]